This test evaluates SNPs associated with increased risk of impaired detoxification capacity especially when exposed to environmental toxins. It also identifies individuals potentially susceptible to adverse drug reactions.
| Analyte List |
|---|
| COMT V158M |
| CYP 1B1 N453S |
| CYP1A1*2A |
| CYP1A1*2C |
| CYP1B1 L432V |
| CYP2A6*2 |
| CYP2C19*2 |
| CYP2C19*3 |
| CYP2C9*2 |
| CYP2C9*3 |
| CYP2D6*3 |
| CYP3A4*17 |
| CYP3A4*1B |
| CYP3A4*3 |
| GSTM1 (glutathione-s-transferase, M, isoforum |
| GSTP1 (glutathione-s-transferase, P, isoforum) GSTP1 |
| NAT 1 R187Q |
| NAT 1 R64W |
| NAT 2 G286E |
| NAT 2 I114T |
| NAT 2 K268R |
| NAT 2 R197Q |
| NAT 2 R64Q |
| SOD 1 A4V |
| SOD 1 G93A |
| SOD-2 (Superoxide dismutase -2) |
| Specimen Requirements |
|---|
| Buccal Swab |